Cargando…

Amelioration of Symptoms and Reduction of VIP Levels after Hepatic Artery Chemoembolization in a Patient with Sandostatin Resistant VIPoma

Vasoactive intestinal polypeptide secreting islet cell tumors (VIPomas) are neuroendocrine tumors that secrete excessive amounts of vasoactive intestinal polypeptide (VIP) that cause distinct syndromes characterized by large-volume diarrhea, hypokalemia, and dehydration. The annual incidence of thes...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shaib, Walid, Mitchell, Kisha, Saif, M. Wasif
Formato:	Texto
Lenguaje:	English
Publicado:	YJBM 2010
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2844690/ https://www.ncbi.nlm.nih.gov/pubmed/20351979

Ejemplares similares

Sandostatin therapy in patients with chronic sarcoidosis
por: Timmermans, Wilhelmina M.C., et al.
Publicado: (2017)

EXTRA-PANCREATIC VIPOMA
por: APODACA-TORREZ, Franz R., et al.
Publicado: (2014)

Metastatic VIPoma presenting as an ovarian mass
por: Mark, Jaron, et al.
Publicado: (2015)

Chronic Diarrhea Secondary to Newly Diagnosed VIPoma
por: Farina, Domenico A., et al.
Publicado: (2019)

Life-Threatening VIPoma Crisis in an Immunocompromised Patient
por: Borhan, Marisa Khatijah, et al.
Publicado: (2021)

Laparoscopic resection of VIPoma presenting at an unusual location
por: Thota, Ravi Kiran, et al.
Publicado: (2022)

Synthesis of somatostatin by breast cancer cells and their inhibition by exogenous somatostatin and sandostatin.
por: Nelson, J., et al.
Publicado: (1989)

The effects of sandostatin (Octreotide, SMS 201-995) infusion on splanchnic and hepatic blood flow in an experimental model of hepatic metastases.
por: Hemingway, D. M., et al.
Publicado: (1992)

MSH2 and CXCR4 involvement in malignant VIPoma
por: Müller, Sven, et al.
Publicado: (2012)

Pancreatic neuroendocrine microadenomatosis presenting as a functional VIPoma
por: Krainev, Alexei A, et al.
Publicado: (2019)

Surgical treatment of metastatic VIPoma: a case report
por: Azizian, Azadeh, et al.
Publicado: (2021)

Treatment options of metastatic and nonmetastatic VIPoma: a review
por: Azizian, Azadeh, et al.
Publicado: (2022)

LBSUN345 Diagnostic Dilemma In A Case of Vipoma
por: Priyadarshini, Shista
Publicado: (2022)

Pharmacokinetic and technical comparison of Sandostatin(® )LAR(® )and other formulations of long-acting octreotide
por: Petersen, Holger, et al.
Publicado: (2011)

Recurrent primary hepatic VIPoma treated with a combination of surgical resection and loco-regional therapy
por: Dahmani, Wafa, et al.
Publicado: (2023)

Octreotida (sandostatin) mas tratamiento convencional en la diarrea refractaria del SIDA.
por: Rosado Castellanos, Marcos Antonio
Publicado: (1995)

Metastatic mixed VIPoma/PPoma-induced diarrhoea causing renal failure
por: Brown, George, et al.
Publicado: (2022)

Multi-visceral resection of pancreatic VIPoma in a patient with sinistral portal hypertension
por: Joyce, David L, et al.
Publicado: (2008)

Ischemic stroke as a presenting feature of VIPoma due to MEN 1 syndrome
por: Maheshwari, Rushikesh Raviraj, et al.
Publicado: (2013)

A Retrospective Interventional Cohort Study to Assess the Safety and Efficacy of Sandostatin LAR for Treatment of Recurrent and/or Refractory Meningiomas
por: Hrachova, Maya, et al.
Publicado: (2020)

Successful Treatment of Hypokalemic Rhabdomyolysis Caused by a Pancreatic VIPoma: A Case Report
por: Ramirez, Sergio, et al.
Publicado: (2019)

Laparoscopic Debridement of Hepatic Necrosis After Hepatic Artery Chemoembolization
por: Tejirian, Talar, et al.
Publicado: (2007)

Case Series of Metastatic VIPoma With Partial Response to Somatostatin Receptor Ligand and Review of Therapeutic Options
por: Wen, Lim Sue, et al.
Publicado: (2021)

Ruptured Hepatic Carcinoma After Transcatheter Arterial Chemoembolization()
por: Jia, Zhongzhi, et al.
Publicado: (2013)

Treatment of patients with metastatic pancreatic and gastrointestinal tumours with the somatostatin analogue Sandostatin: a phase II study including endocrine effects.
por: Klijn, J. G., et al.
Publicado: (1990)

Activation of VIP interneurons in the prefrontal cortex ameliorates neuropathic pain aversiveness
por: Li, Miao, et al.
Publicado: (2022)

Prevalence of Diagnostic Methods and Treatment Modalities in Vipoma Patients: A Rare Cause of Hormone-Mediated Diarrhea
por: Amiri, Fateme Shamekhi
Publicado: (2019)

Pancreatic VIPoma as a Differential Diagnosis in Chronic Pediatric Diarrhea: A Case Report and Review of the Literature
por: Bonilla Gonzalez, Carolina, et al.
Publicado: (2021)

SAT-432 MTD201 Has a Favourable 28-Day Sustained Release Profile Compared to Sandostatin LAR in Healthy Subjects
por: Seaman, Paul, et al.
Publicado: (2019)

Pharmacokinetics of Mitomycin C Following Hepatic Arterial Chemoembolization With Gelfoam
por: Ding, Jin Wen, et al.
Publicado: (1992)

Transcatheter Arterial Chemoembolization Based on Hepatic Hemodynamics for Hepatocellular Carcinoma
por: Murata, Satoru, et al.
Publicado: (2013)

VIP Visit
Publicado: (1998)

VIP Visit
Publicado: (1999)

The clinical and cost-effectiveness of a Victim Improvement Package (VIP) for the reduction of chronic symptoms of depression or anxiety in older victims of common crime (the VIP trial): study protocol for a randomised controlled trial
por: Serfaty, Marc, et al.
Publicado: (2020)

Hepatic Artery Chemoembolization for Hepatocellular Carcinoma Recurrence Confined to the Transplanted Liver
por: Carr, Brian I.
Publicado: (2012)

Construction of pain prediction model for patients undergoing hepatic arterial chemoembolization
por: Song, Ping-Wei, et al.
Publicado: (2023)

Infiltrative Hepatocellular Carcinoma: Transcatheter Arterial Chemoembolization Versus Hepatic Arterial Infusion Chemotherapy
por: An, Chao, et al.
Publicado: (2021)

Plasma levels of VIP are not elevated during PACAP- and VIP-induced cluster headache attacks: an exploratory study
por: Deligianni, Christina, et al.
Publicado: (2023)

Arterial chemoembolization with cisplatin microcapsules.
por: Okamoto, Y., et al.
Publicado: (1986)

Transarterial chemoembolization with hepatic arterial infusion chemotherapy plus S-1 for hepatocellular carcinoma
por: Guo, Jian-Hai, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_8ml8v1p6t2o1s9obcv5006bpqq